|
Orthologous residues
|
|
ZAP70 (human): Y493‑p, ZAP70 (mouse): Y492‑p, ZAP70 (rat): Y488‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mutation of modification site, peptide sequencing, phosphoamino acid analysis, phosphopeptide mapping
|
|
Disease tissue studied:
lymphoma, B cell lymphoma
|
|
Relevant cell lines - cell types - tissues:
DT40 (B lymphocyte), Jurkat (T lymphocyte), SF9
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
chicken, human, insect
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
Lck (human)
|
modification site within consensus motif, phosphopeptide analysis, genetic transfer of wild-type enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
anti-TCR
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
enzymatic activity, induced
|
|
Effect of modification (process):
transcription, altered
|